Skip to content ↓

Recent Course X grad named one of Forbes magazine's '30 Under 30'

Pedro Valencia PhD '12 honored for drug research.
Pedro Valencia
Caption:
Pedro Valencia
Credits:
Photo courtesy of the Department of Chemical Engineering

Pedro Valencia, who earned his PhD in chemical engineering at MIT in November, was named in Forbes magazine's 2012 list of the top 30 rising stars in science and health.

Valencia was cited for figuring out "how to more quickly synthesize nanoparticles that can be used to make drugs more effective and less toxic and to put multiple drugs inside the same nanotech medicine. This has resulted in many top-notch scientific publications and the formation of a start-up, Blend Therapeutics."

Valencia, a former student of Robert Langer, the David H. Koch Institute Professor, earned his BS in chemical engineering from the University of Wisconsin-Madison in 2007, and was at the top of his class. He completed his MS in chemical engineering practice at MIT in 2009.

Valencia was the recipient of the NSF Graduate Fellowship. He was co-advised by Professor Langer and Dr. Omid Farokhzad of the Brigham Women's Hospital - Harvard Medical School.

Related Links

Related Topics

More MIT News

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story